Construction of network pharmacology-based approach and potential mechanism from major components of Coriander sativum L. against COVID-19

Islamie, Ridho and Iksen, Iksen and Buana, Bayu Cakra and Gurning, Kasta and Syahputra, Hariyadi Dharmawan and Winata, Hanafis Sastra (2022) Construction of network pharmacology-based approach and potential mechanism from major components of Coriander sativum L. against COVID-19. Pharmacia, 69 (3). pp. 689-697. ISSN 0428-0296; E-ISSN 2603-557X

PDF Ridho Islamie_Construction of network pharmacology.pdf Download (2MB)

Abstract

Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Despite the fact that various therapeutic compounds have shown potential prevention or treatment, no specific medicine has been developed for the COVID-19 pandemic. Natural products have recently been suggested as a possible treatment option for COVID-19 prevention and treatment. This study focused on the potential of Coriander sativum L. (CSL) against COVID-19 based on network pharmacology approach. Interested candidates of CSL were identified by searching accessible databases for protein–protein interactions with the COVID-19. An additional GO and KEGG pathway analysis was carried out in order to identify the related mechanism of action. In the end, 51 targets were obtained through network pharmacology analysis with EGFR, AR, JAK2, PARP1, and CTSB become the core target. CSL may have favorable effects on COVID-19 through a number of important pathways, according to GO and KEGG pathway analyses. These findings suggest that CSL may prevent and inhibit the several processes related to COVID-19.

Item Type:	Article
Uncontrolled Keywords:	Network pharmacology, COVID-19, Coriander sativum L., Protein interaction
Subjects:	R Medicine > RS Pharmacy and materia medica
Divisions:	Faculty of Pharmacy > Department of Pharmacy
Depositing User:	RIDHO ISLAMIE
Date Deposited:	27 Jul 2022 06:20
Last Modified:	22 Oct 2024 04:42
URI:	http://repository.ubaya.ac.id/id/eprint/42224

Actions (login required)

View Item